Structural damages in adsorbed vaccines affected by freezing

Biologicals

Volumn 41, Issue 2, 2013, Pages 71-76

  Kurzatkowski, Wiesław ^a   Kartoĝlu, ümit ^b   Staniszewska, Monika ^a   Górska, Paulina ^a   Krause, Aleksandra ^a   Wysocki, Mirosław Jan ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Adsorbed vaccines; Aluminium; Freeze damage; Scanning electron microscopy; Shake test; X ray analysis

Indexed keywords

ADSORBED VACCINE; ADSORBENT; ALUMINUM; ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PHOSPHATE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG STRUCTURE; FLOCCULATION; FREEZING; MOLECULAR SIZE; MOLECULAR WEIGHT; PHYSICAL PARAMETERS; PRECIPITATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STRUCTURAL DAMAGE; STRUCTURE ANALYSIS; SURFACE PROPERTY; X RAY ANALYSIS;

ADSORPTION; CHEMISTRY TECHNIQUES, ANALYTICAL; FLOCCULATION; FREEZING; HUMANS; MICROSCOPY, ELECTRON, SCANNING; SURFACE PROPERTIES; VACCINES; X-RAYS;

EID: 84875266561     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.10.011     Document Type: Article

References (22)

1. Milstien J., Kartoglu U., Zaffran M. Temperature sensitivity of vaccines 2006, World Health Organization, Geneva, (WHO/IVB/06.10).
2. Burgess M.A., McIntyre P.B. Vaccines and the cold chain: is it too hot.or too cold?. Med J Aust 1999, 171:82. PMID:10474582.
3. Milhomme P. Cold chain study: danger of freezing vaccines. Can Commun Dis Rep 1993, 19:33-38. PMID:8467304.
4. Lugosi L., Battersby A. Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. Bull World Health Organ 1990, 68:431-439. PMID:2208556.
5. Hanjeet K., Lye M.S., Sinniah M., Schnur A. Evaluation of cold chain monitoring in Kelantan, Malaysia. Bull World Health Organ 1996, 74:391-397. PMID:8823961.
6. Jeremijenko A., Kelly H., Sibthorpe B., Attewell R. Improving vaccine storage in general practice refrigerators. BMJ 1996, 312:1651-1652. PMID:8664720.
7. Thakker Y., Woods S. Storage of vaccines in the community: weak link in the cold chain?. BMJ 1992, 304:756-758. PMID:1571683. 10.1136/bmj.304.6829.756.
8. Wawryk A., Mavromatis C., Gold M. Electronic monitoring of vaccine cold chain in a metropolitan area. BMJ 1997, 315:518. PMID:9329306.
9. Bishai D.M., Bhatt S., Miller L.T., Hayden G.F. Vaccine storage practices in pediatric offices. Pediatrics 1992, 89:193-196. PMID:1734382.
10. Bell K.N., Hogue C.J., Manning C., Kendal A.P. Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics 2001, 107:e100. PMID:11389298. 10.1542/peds.107.6.e100.
11. Wirkas T., Toikilik S., Miller N., Morgan C., Clements C.J. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine 2007, 25:691-697. PMID:16968657. 10.1016/j.vaccine.2006.08.028.
12. Matthias D.M., Robertson J., Garrison M.M., Newland S., Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine 2007, 25:3980-3986. PMID:17382434. 10.1016/j.vaccine.2007.02.052.
13. World Health Organization The effects of freezing on the appearance, potency, and toxicity of adsorbed and unadsorbed DTP vaccines. Wkly Epidemiol Rec 1980, 55:385-392.
14. Dietz V., Gałazka A., van Loon F., Cochi S. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ 1997, 75:81-93. PMID:9141753.
15. Hem S.L., HogenEsch H. Aluminum containing adjuvants: properties, formulation and use. Vaccine adjuvants and delivery systems 2007, 92-93. Wiley-Interscience, New Jersey. M. Singh (Ed.).
16. Boros C.A., Hanlon M., Gold M.S., Roberton D.M. Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines. Vaccine 2001, 19(25-26):3537-3542.
17. Mansoor O., Pillans P.L. Vaccine adverse events reported in New Zealand 1990-95. NZ Med J 1997, 110:270-272. PMID:9269289.
18. Davaalkham D., Ojima T., Wiersma S., Lkhagvasuren T., Nymadawa P., Uehara R., et al. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey. J Epidemiol Community Health 2007, 61:578-584.
19. Chen D., Tyagi A., Carpenter J., Perkins S., Sylvester D., Guy M., et al. Characterization of freeze sensitivity of hepatitis B vaccine. Hum Vaccine 2009, 5(1):26-32.
20. Kartoglu U., Ozguler N.K., Wolfson L.J., Kurzatkowski W. Validation of the shake test for detecting freeze damage to adsorbed vaccines. Bull World Health Organ 2010, 88:624-631. 10.2471/BLT.08.056879.
21. World Health Organization. Shake and tell: shake test works (Video article), [accessed on 05.07.11]. http://vimeo.com/8381355.
22. Aleksandrowicz J., Drozdz M., Fiejka M., Kurzatkowski W. Evaluation of the physico-chemical state of aluminium hydroxide in biopreparations stored in various conditions [in Polish]. Exp Med Microbiol 1990, 42:163-170.